PUBLISHER: Allied Market Research | PRODUCT CODE: 1097729
PUBLISHER: Allied Market Research | PRODUCT CODE: 1097729
Transcatheter mitral valve repair and replacement is a minimally invasive technique for the treatment of heart-associated diseases such as mitral valve stenosis, mitral valve prolapses, and mitral valve regurgitation. In case of mitral valve misfunctioning, an individual can experience symptom such as fatigue and shortness of breath. Mitral valve diseases occurs when mitral valve does not pump enough blood out of the left ventricular chamber to supply the body with oxygen-filled blood. Mitral valve disorders are severe, if untreated, they may lead to heart failure and irregular heartbeats called arrhythmias.
The major factors that drive the growth of the global transcatheter mitral valve repair and replacement market include increase in incidence of heart diseases especially among the geriatric population, technological advancements, and introduction of novel mitral valves. However, implementation of stringent regulations by governing bodies for the approval of novel mitral valve stents, high cost of mitral valve surgeries, and risks associated with this procedure restrain the market growth. Conversely, continuous product innovations and introduction of novel mitral valves in untapped economies are anticipated to create lucrative opportunities for key market players.
The global transcatheter mitral valve repair and replacement market is segmented into product, indication, and region. According to product, the market is divided into mechanical valves and bioprosthetic tissue (biological) valves. By indication, it is categorized into mitral valve stenosis, mitral valve prolapses, and mitral valve regurgitation. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The major companies profiled in the report include: LivaNova Plc., Abbott Laboratories, Biotronik Pvt., Ltd., Edward Lifesciences, Medtronic Plc., Neovasc Inc., NeoChord, St. Jude Medical, Direct Flow Medical Inc., and Colibri Heart Valve, LLC.
Key Benefits For Stakeholders
By Indications
By BY PRODUCT
By Region